Aspiriant Holdings S3’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.09M Buy
107,030
+12,110
+13% +$254K 0.9% 42
2015
Q3
$1.92M Buy
94,920
+14,600
+18% +$319K 0.88% 44
2015
Q2
$1.97M Buy
80,320
+38,040
+90% +$974K 0.79% 50
2015
Q1
$1.03M Buy
42,280
+4,980
+13% +$121K 0.41% 66
2014
Q4
$891K Buy
37,300
+2,455
+7% +$61.4K 0.37% 72
2014
Q3
$885K Buy
34,845
+5,530
+19% +$149K 0.36% 70
2014
Q2
$763K Buy
29,315
+2,655
+10% +$67K 0.3% 77
2014
Q1
$649K Buy
+26,660
New +$618K 0.27% 81

Other funds holding SCHE

Aspiriant Holdings S3's SCHE Position: Q4 2015 in Review

Aspiriant Holdings S3 increased its Schwab Emerging Markets Equity ETF (SCHE) stake by 13% in Q4 2015, buying an estimated $254K and bringing the position to 107,030 shares worth $2.09M. The position accounts for 0.9% of the portfolio, ranked #42.

Aspiriant Holdings S3 first reported a position in SCHE in Q1 2014 and has held it in 8 quarters since. 185 funds tracked by Wall St. Rank hold SCHE as of Q4 2015.

  • Aspiriant Holdings S3 held 107,030 shares of Schwab Emerging Markets Equity ETF worth $2.09M as of Q4 2015.
  • Aspiriant Holdings S3 bought 12,110 Schwab Emerging Markets Equity ETF shares in Q4 2015, an estimated $254K.
  • Schwab Emerging Markets Equity ETF made up 0.9% of Aspiriant Holdings S3's portfolio in Q4 2015, its #42 holding.
  • Aspiriant Holdings S3 first reported a position in Schwab Emerging Markets Equity ETF in Q1 2014 and has held it in 8 quarters since.
  • 185 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.